{"id":186460,"date":"2026-08-05T14:09:28","date_gmt":"2026-08-05T08:39:28","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=186460"},"modified":"2026-08-05T14:09:28","modified_gmt":"2026-08-05T08:39:28","slug":"sms-lifesciences-india-ltd-share-price-fall-2026-08-05","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sms-lifesciences-india-ltd-share-price-fall-2026-08-05\/","title":{"rendered":"SMS Lifesciences India Ltd. (HALEOSLABS) Share Price Falls 9.02% Amid Market Volatility"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;;margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/haleoslabs\/sms-lifesciences-india-ltd-share-price-today\">SMS Lifesciences India Ltd.<\/a> Share Price fell 9.02% to Rs 1,440, with a market cap of Rs 478.54 crore.<\/p>\n<p style=\"margin-top:0!important;\">SMS Lifesciences India Ltd. Share Price experienced a significant decline today, falling 9.02% to close at Rs 1,440. This drop comes in the context of a micro-cap market capitalisation of Rs 478.54 crore. The stock opened at Rs 1,510.05 and reached a high of the same before tumbling to a low of Rs 1,440. The day&#8217;s turnover was Rs 0.01 crore, with a total volume of 1,180 shares traded across BSE and NSE.  Investors are closely monitoring the situation as the stock&#8217;s performance today has raised questions about its short-term trajectory.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"SMS_Lifesciences_India_Ltd_HALEOSLABS_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>SMS Lifesciences India Ltd. (HALEOSLABS) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,440<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,582.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -142.85 (-9.02%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,510.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,510.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,440<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">53<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">53<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,127<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,180<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.01 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 478.54 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/table>\n<p>SMS Lifesciences India Ltd. (HALEOSLABS) traded at Rs 1,440. versus the previous close of Rs 1,582.85, a fall of 9.02%. The stock opened at Rs 1,510.05, reached Rs 1,510.05, touched Rs 1,440. Reported volume was 53.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"SMS_Lifesciences_India_Ltd_HALEOSLABS_Fundamental_Analysis\"><\/span><strong>SMS Lifesciences India Ltd. (HALEOSLABS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 478.54 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.64x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.24x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.07%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 57.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.09%<\/td>\n<\/tr>\n<\/table>\n<p>SMS Lifesciences India Ltd. was valued at a P\/E ratio of 27.64x, a P\/B ratio of 2.24x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 11.07% and ROCE of 12.96%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs 57.26, dividend yield of 0.09%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<p>From a fundamental perspective, SMS Lifesciences India Ltd. has a market capitalisation of Rs 478.54 crore. The company&#8217;s price-to-earnings (P\/E) ratio is 27.64, which is slightly above the industry median of 25.82 but below the average of 80.86, indicating a relatively fair valuation. The price-to-book (P\/B) ratio stands at 2.24, compared to the industry median of 1.85, suggesting a higher valuation relative to its book value. The return on equity (ROE) is 11.07%, slightly above the industry median of 10.59%, while the return on capital employed (ROCE) is 12.96%, just below the industry median of 12.98%. The company&#8217;s earnings per share (EPS) is Rs 57.26, and it offers a dividend yield of 0.09%, reflecting a modest payout to shareholders. These fundamentals provide a mixed picture, with some metrics indicating strength while others suggest caution. Investors should weigh these factors carefully when considering the stock&#8217;s potential.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.64x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">80.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.39x to 3,385.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.24x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.07%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.59%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.98%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 478.54 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 146.67 crore<\/td>\n<\/tr>\n<\/table>\n<p>SMS Lifesciences India Ltd. (HALEOSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>SMS Lifesciences India Ltd. (HALEOSLABS) has a P\/E ratio of 27.64x, which is above the benchmark median of 25.82x, a difference of +7.05%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>SMS Lifesciences India Ltd. (HALEOSLABS) has a ROE of 11.07%, which is above the benchmark median of 10.59%, a difference of +4.53%. SMS Lifesciences India Ltd. (HALEOSLABS) has a ROCE of 12.96%, which is below the benchmark median of 12.98%, a difference of -0.15%.<\/p>\n<p>Track today&#8217;s top decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>SMS Lifesciences India Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals &#038; Drugs industry. The sector snapshot reveals that the company&#8217;s P\/E ratio of 27.64 is above the industry median of 25.82 but below the average of 80.86, indicating a relatively balanced valuation. The P\/B ratio of 2.24 is higher than the industry median of 1.85, suggesting a premium valuation. The company&#8217;s ROE of 11.07% is slightly above the industry median of 10.59%, while its ROCE of 12.96% is just below the industry median of 12.98%. The market capitalisation of Rs 478.54 crore places it below the industry median of Rs 146.67 crore, highlighting its position as a smaller player in the sector. With 137 companies in the benchmark, SMS Lifesciences India Ltd. faces competition from larger and more established peers. Understanding these sector dynamics is crucial for investors assessing the company&#8217;s market position and growth potential.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,945.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">30.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,835.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,652.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,608.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">63.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,589.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<\/table>\n<p>SMS Lifesciences India Ltd. (HALEOSLABS) has a P\/E ratio of 27.64x compared with the displayed peer median of 30.21x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.07% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 12.96% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. SMS Lifesciences India Ltd. (HALEOSLABS) has a market capitalisation of Rs 478.54 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<p>In comparison to its peers, SMS Lifesciences India Ltd. presents a mixed profile. The company&#8217;s P\/E ratio of 27.64 is lower than that of Kwality Pharmaceuticals Ltd. (39.86) and Beta Drugs Ltd. (63.2), but higher than Venus Remedies Ltd. (17.74). Its P\/B ratio of 2.24 is comparable to Hikal Ltd. (2.35) and Solara Active Pharma Sciences Ltd. (1.97). The ROE of 11.07% is below Kwality Pharmaceuticals Ltd. (28.21%) but above Venus Remedies Ltd. (9.85%). The ROCE of 12.96% is lower than Beta Drugs Ltd. (22.17%) but higher than Panacea Biotec Ltd. (5.36%). With a market capitalisation of Rs 478.54 crore, SMS Lifesciences India Ltd. is smaller compared to its peers, such as Dishman Carbogen Amcis Ltd. (Rs 2,945.17 crore) and Hikal Ltd. (Rs 2,835.92 crore). These comparisons highlight the company&#8217;s relative strengths and weaknesses within the industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SMS_Lifesciences_India_Ltd\"><\/span><strong>Why Investors Are Watching SMS Lifesciences India Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are closely monitoring SMS Lifesciences India Ltd. due to its recent price decline and its position within the competitive Pharmaceuticals &#038; Drugs industry. The company&#8217;s technical and fundamental indicators provide a mixed outlook, prompting further analysis.<\/p>\n<ul>\n<li>Price Action: 9.02% decline to Rs 1,440.<\/li>\n<li>Technical Position: RSI at 48.59, below key moving averages.<\/li>\n<li>Fundamental Context: P\/E of 27.64, ROE of 11.07%.<\/li>\n<li>Ownership: No significant changes reported.<\/li>\n<li>Sector Positioning: Operates in a competitive industry with 137 peers.<\/li>\n<\/ul>\n<p>Investors should continue to monitor the company&#8217;s performance, particularly in light of its valuation metrics and sector dynamics, to make informed decisions.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_SMS_Lifesciences_India_Ltd\"><\/span><strong>About SMS Lifesciences India Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SMS Lifesciences India Ltd. is a prominent player in the Pharmaceuticals &#038; Drugs industry, operating within the broader Healthcare sector. The company is engaged in the development, manufacture, and sale of active pharmaceutical ingredients (APIs) and intermediates. Its product portfolio includes a wide range of therapeutic categories, catering to both domestic and international markets. With a focus on quality and innovation, SMS Lifesciences India Ltd. aims to maintain its competitive edge in the industry. The company&#8217;s operations are supported by state-of-the-art manufacturing facilities and a dedicated research and development team. As a micro-cap entity, it faces challenges from larger competitors but continues to strive for growth and market expansion.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_SMS_Lifesciences_India_Ltd_Share_Price_on_Univest\"><\/span><strong>Track SMS Lifesciences India Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/haleoslabs\/sms-lifesciences-india-ltd-share-price-today\">SMS Lifesciences India Ltd. (HALEOSLABS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners lists and related market analysis.<\/p>\n<p>Investors can track SMS Lifesciences India Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on technical indicators, fundamental ratios, shareholding patterns, and 52-week levels. Stay informed with the latest market insights and analysis to make well-informed investment decisions. Univest offers a platform for tracking the performance of SMS Lifesciences India Ltd. and other stocks in the Healthcare sector.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_caused_the_decline_in_SMS_Lifesciences_India_Ltd_Share_Price\"><\/span><strong>What caused the decline in SMS Lifesciences India Ltd. Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The decline in SMS Lifesciences India Ltd. Share Price by 9.02% today does not have a specific company-related catalyst. Market volatility and sector dynamics may have influenced the price movement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_price_of_SMS_Lifesciences_India_Ltd_shares\"><\/span><strong>What is the current price of SMS Lifesciences India Ltd. shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current price of SMS Lifesciences India Ltd. shares is Rs 1,440, following a 9.02% decline from the previous close of Rs 1,582.85. The stock moved -9.02% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SMS_Lifesciences_India_Ltds_PE_ratio_compare_to_the_industry\"><\/span><strong>How does SMS Lifesciences India Ltd.&#39;s P\/E ratio compare to the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Lifesciences India Ltd.&#39;s P\/E ratio of 27.64 is above the industry median of 25.82 but below the industry average of 80.86, indicating a relatively balanced valuation. The company trades at a P\/E ratio of 27.64x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_SMS_Lifesciences_India_Ltd\"><\/span><strong>What is the market capitalisation of SMS Lifesciences India Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Lifesciences India Ltd. has a market capitalisation of Rs 478.54 crore, categorising it as a micro-cap company within the Pharmaceuticals &amp; Drugs industry. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SMS_Lifesciences_India_Ltds_ROE_compare_to_its_peers\"><\/span><strong>How does SMS Lifesciences India Ltd.&#39;s ROE compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Lifesciences India Ltd.&#39;s ROE of 11.07% is below Kwality Pharmaceuticals Ltd. (28.21%) but above Venus Remedies Ltd. (9.85%), indicating a moderate return on equity. ROE stands at 11.07%. ROCE stands at 12.96%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SMS_Lifesciences_India_Ltds_PB_ratio_compare_to_the_industry\"><\/span><strong>How does SMS Lifesciences India Ltd.&#39;s P\/B ratio compare to the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Lifesciences India Ltd.&#39;s P\/B ratio of 2.24 is higher than the industry median of 1.85, suggesting a premium valuation relative to its book value. The company trades at a P\/E ratio of 27.64x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_sector_context_for_SMS_Lifesciences_India_Ltd\"><\/span><strong>What is the sector context for SMS Lifesciences India Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SMS Lifesciences India Ltd. operates in the Healthcare sector, specifically in the Pharmaceuticals &amp; Drugs industry, competing with 137 peers in the benchmark. The stock belongs to the Healthcare sector.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SMS Lifesciences India Ltd. Share Price rises to Rs Rs 1,440. marking a 9.02% rise today. clearing the 8.1% threshold for Micro Cap stocks. Market cap stands at<\/p>\n","protected":false},"author":29,"featured_media":186457,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-186460","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["186457"],"rank_math_title":["SMS Lifesciences India Ltd. Share Price Today: 9.02% Drop"],"rank_math_description":["SMS Lifesciences India Ltd. Share Price fell 9.02% today. Explore price, technical, fundamental, ownership, and sector analysis for deeper insights."],"rank_math_focus_keyword":["SMS Lifesciences India Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/SMS_Lifesciences_India_Ltd_HALEOSLABS_Share_Price_Falls_902_Amid_Market_Volatility_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/186460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=186460"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/186460\/revisions"}],"predecessor-version":[{"id":186461,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/186460\/revisions\/186461"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/186457"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=186460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=186460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=186460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}